Getty Images Understanding current trends in the incidence, prevalence, and distribution of ulcerative colitis can help inform diagnosis and treatment. Most incidence and prevalence studies for UC ...
Oral presentation of Phase 2b, 96-week, open-label, maintenance efficacy and safety in obefazimod-treated patients with moderately to severely active ulcerative colitis (UC) Moderated poster ...
CRANBURY, N.J., Oct. 16, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the ...
Significant advances in ulcerative colitis care prompted an update to the American College of Gastroenterology (ACG) guideline for moderately to severely active disease in adults. In recent years, a ...
NEW YORK, Oct. 16, 2023 /PRNewswire/ -- Immunic, Inc. (IMUX) (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic ...
Ankylosing spondylitis and ulcerative colitis are distinct conditions that affect different body parts. But having one may cause symptoms that resemble the other and even increase your risk of ...
Share on Pinterest Ulcerative colitis treatment drug Omvoh, from Eli Lilly, was linked to sustained clinical remission after 4 years, according to new trial data. Image credit: Plexi ...
Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. Ulcerative colitis may cause ...
Ulcerative colitis can lead to changes in your stool's texture, color, and smell. You may notice increased bowel movement frequency, which can disrupt your daily life and sleep. Frequent diarrhea and ...
A new drug, investigated by Amsterdam University Medical Centers together with colleagues around the world, is effective as a treatment against ulcerative colitis. With the clinical trial ...
For hospitalized inflammatory bowel disease (IBD) patients, malnutrition contributes to readmission, mortality, length of stay (LOS), and health care costs, according to a study published online Jan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results